From Technical Performance to Assistive Validity: A Critical Review of Evaluation Approaches for AI-Enabled Assistive Technology. [PDF]
Giraldo M, Sacchi F.
europepmc +1 more source
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau +11 more
wiley +1 more source
Access to assistive technology in Africa: findings from evidence-informed deliberative dialogues on trade and fiscal policies. [PDF]
Gaiotto EMG +7 more
europepmc +1 more source
This paper describes a collaborative strategy shared by a rehabilitation center and a public usniversity with a goal to improve the knowledge on assistive technology and rehabilitation research and development in Brazil.
Rodrigues, Ana Cláudia Tavares +3 more
core
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch +5 more
wiley +1 more source
A modified hybrid hub-spoke model for assistive technology: institutional design for procurement, financing, and market-shaping. [PDF]
Radosavljević G, Lazevski A.
europepmc +1 more source
Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias +3 more
wiley +1 more source
Evaluating OCR performance for assistive technology: effects of walking speed, camera placement, and camera type. [PDF]
Feng J +7 more
europepmc +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
From aid dependency to market transformation: harnessing international trade and innovative business models to revitalize the assistive technology ecosystem in Africa. [PDF]
Pakouyowou MT.
europepmc +1 more source

